Pre-Made Eftansomatropin Alfa Biosimilar, Fusion Protein targeting GHR fused with human IGHG4 Fc (Fragment constant): Recombinant therapeutic protein targeting GHBP/GHIP for drug discovery and mechanism of action (MOA) research

Pre-Made Eftansomatropin Alfa Biosimilar, Fusion Protein targeting GHR fused with human IGHG4 Fc (Fragment constant): Recombinant therapeutic protein targeting GHBP/GHIP is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Eftansomatropin alfa is a potential highly differentiated long-acting recombinant human growth hormone being developed as a more convenient and effective therapy for growth hormone deficiency (GHD). Eftansomatropin alfa contains hGH-hyFc (GX-H9) which is a recombinant human growth hormone prepared by fusing hybrid Fc to human growth hormone hGH. Like endogenous growth hormone, eftansomatropin alfa stimulates the production of insulin-like growth factor 1 (IGF-1) in the liver, which has growth-stimulating effects on a variety of tissues, including osteoblast and chondrocyte activities that stimulate bone growth.

Order information

* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

Catalog No.	Package	Price(In USD)	Qty (Quantity)	Sum(In USD)
GMP-Bios-INN-827-1mg	1mg	3090
GMP-Bios-INN-827-10mg	10mg	Inquiry
GMP-Bios-INN-827-100mg	100mg	Inquiry
GMP-Bios-INN-827-xmg	≥100mg	Inquiry
			Shipping Cost:	760.00
			Total:

Description

Products Name (INN Index)	Pre-Made Eftansomatropin Alfa Biosimilar, Fusion Protein targeting GHR fused with human IGHG4 Fc (Fragment constant): Recombinant therapeutic protein targeting GHBP/GHIP
INN Name	Eftansomatropin Alfa
Target	GHR
Format	Fusion Protein
Derivation	human
Species Reactivity	human
CH1 Isotype	Fusion - [GH1 (growth hormone 1, somatotropin, GH, GH-N, GHN, hGH- N, pituitary growth hormone)]1 - IGHG4 Fc (Fragment constant)
VD LC	Fusion - [GH1 (growth hormone 1, somatotropin, GH, GH-N, GHN, hGH- N, pituitary growth hormone)]1 - IGHG4 Fc (Fragment constant)
Highest_Clin_Trial (Jan '20)
Est. Status
100% SI Structure
99% SI Structure
95-98% SI Structure
Year Proposed
Year Recommended
Companies	Genexine (Seongnam South Korea)
Conditions Approved
Conditions Active
Conditions Discontinued
Development Tech	0